Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer's disease treatment
{{output}}
Alzheimer's disease (AD) is characterized by a long preclinical phase lasting more than a decade before the onset of its clinical phase of mild cognitive impairment (MCI) or dementia. Recent advances in psychedelic research underscore numerous neuroplastogeni... ...
